Article
Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway.
Clinical genetics - 1 Jan 2009
Do R, Kiss R S, Gaudet D, Engert J C
Abstract excerpt
High levels of plasma low-density lipoprotein cholesterol (LDL-C) are a significant risk factor for heart disease. Statins (3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors) have been extensively used to treat high-plasma LDL-C levels and are effective in preventing heart disease. However, statins can be associated with adverse side effects in some patients and do not work effectively in others. As an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
